Update on Clinical Trials in Belgium
12:00 ? 13:00 Registration and lunch / networking 13:00 ? 14:00 Update on Clinical Trials in Belgium Duo presentation by: Nathalie Lambot, Expert Public Health: Clinical Trials-Regulatory Affairs, Pharma.be Stefaan Vancayzeele, CSO Novartis Pharma, Vice-president BeAPP 14:00 ? 14:30 Q&A 14:30 ? 15:30 BeAPP extra general assemblee meeting All BeAPP members are kindly invited to discuss new BeAPP bylaws, as proposed by BeAPP Board.